Inspection-Challenged FDA Defies Odds By Issuing Most Quality-Related Warning Letters Since 2017
US FDA data shared with Medtech Insight show that the number of quality-related warning letters sent to device manufacturers in calendar year 2021 ticked up 33% from 2020. Last year’s enforcement missives were also the most handed out by the agency in four years.
